Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner

被引:186
作者
Cano-Rodriguez, David [1 ]
Gjaltema, Rutger A. F. [1 ]
Jilderda, Laura J. [1 ]
Jellema, Pytrick [1 ]
Dokter-Fokkens, Jelleke [1 ]
Ruiters, Marcel H. J. [1 ]
Rots, Marianne G. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Epigenet Editing Res Grp, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
基金
欧盟地平线“2020”;
关键词
ARTIFICIAL TRANSCRIPTION FACTORS; HISTONE MODIFICATIONS; DNA METHYLATION; CHROMATIN REGULATORS; ENDOGENOUS GENES; EXPRESSION; METHYLTRANSFERASE; ACTIVATION; CANCER; COMBINATORIAL;
D O I
10.1038/ncomms12284
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Histone modifications reflect gene activity, but the relationship between cause and consequence of transcriptional control is heavily debated. Recent developments in rewriting local histone codes of endogenous genes elucidated instructiveness of certain marks in regulating gene expression. Maintenance of such repressive epigenome editing is controversial, while stable reactivation is still largely unexplored. Here we demonstrate sustained gene re-expression using two types of engineered DNA-binding domains fused to a H3K4 methyltransferase. Local induction of H3K4me3 is sufficient to allow re-expression of silenced target genes in various cell types. Maintenance of the re-expression is achieved, but strongly depends on the chromatin microenvironment (that is, DNA methylation status). We further identify H3K79me to be essential in allowing stable gene re-expression, confirming its role in epigenetic crosstalk for stable reactivation. Our approach uncovers potent epigenetic modifications to be directly written onto genomic loci to stably activate any given gene.
引用
收藏
页数:11
相关论文
共 62 条
[1]   PRDM9 Is a Major Determinant of Meiotic Recombination Hotspots in Humans and Mice [J].
Baudat, F. ;
Buard, J. ;
Grey, C. ;
Fledel-Alon, A. ;
Ober, C. ;
Przeworski, M. ;
Coop, G. ;
de Massy, B. .
SCIENCE, 2010, 327 (5967) :836-840
[2]   Reprogramming epigenetic silencing:: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor [J].
Beltran, Adriana S. ;
Sun, Xueguang ;
Lizard, Paul M. ;
Blancafort, Pilar .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (05) :1080-1090
[3]   Suppression of Breast Tumor Growth and Metastasis by an Engineered Transcription Factor [J].
Beltran, Adriana S. ;
Russo, Angela ;
Lara, Haydee ;
Fan, Cheng ;
Lizardi, Paul M. ;
Blancafort, Pilar .
PLOS ONE, 2011, 6 (09)
[4]   Linking DNA methylation and histone modification: patterns and paradigms [J].
Cedar, Howard ;
Bergman, Yehudit .
NATURE REVIEWS GENETICS, 2009, 10 (05) :295-304
[5]   Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter [J].
Chen, Hui ;
Kazemier, Hinke G. ;
de Groote, Marloes L. ;
Ruiters, Marcel H. J. ;
Xu, Guo-Liang ;
Rots, Marianne G. .
NUCLEIC ACIDS RESEARCH, 2014, 42 (03) :1563-1574
[6]   Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system [J].
Cheng, Albert W. ;
Wang, Haoyi ;
Yang, Hui ;
Shi, Linyu ;
Katz, Yarden ;
Theunissen, Thorold W. ;
Rangarajan, Sudharshan ;
Shivalila, Chikdu S. ;
Dadon, Daniel B. ;
Jaenisch, Rudolf .
CELL RESEARCH, 2013, 23 (10) :1163-1171
[7]   Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes [J].
de Groote, Marloes L. ;
Verschure, Pernette J. ;
Rots, Marianne G. .
NUCLEIC ACIDS RESEARCH, 2012, 40 (21) :10596-10613
[8]   Modeling gene expression using chromatin features in various cellular contexts [J].
Dong, Xianjun ;
Greven, Melissa C. ;
Kundaje, Anshul ;
Djebali, Sarah ;
Brown, James B. ;
Cheng, Chao ;
Gingeras, Thomas R. ;
Gerstein, Mark ;
Guigo, Roderic ;
Birney, Ewan ;
Weng, Zhiping .
GENOME BIOLOGY, 2012, 13 (09)
[9]   An integrated encyclopedia of DNA elements in the human genome [J].
Dunham, Ian ;
Kundaje, Anshul ;
Aldred, Shelley F. ;
Collins, Patrick J. ;
Davis, CarrieA. ;
Doyle, Francis ;
Epstein, Charles B. ;
Frietze, Seth ;
Harrow, Jennifer ;
Kaul, Rajinder ;
Khatun, Jainab ;
Lajoie, Bryan R. ;
Landt, Stephen G. ;
Lee, Bum-Kyu ;
Pauli, Florencia ;
Rosenbloom, Kate R. ;
Sabo, Peter ;
Safi, Alexias ;
Sanyal, Amartya ;
Shoresh, Noam ;
Simon, Jeremy M. ;
Song, Lingyun ;
Trinklein, Nathan D. ;
Altshuler, Robert C. ;
Birney, Ewan ;
Brown, James B. ;
Cheng, Chao ;
Djebali, Sarah ;
Dong, Xianjun ;
Dunham, Ian ;
Ernst, Jason ;
Furey, Terrence S. ;
Gerstein, Mark ;
Giardine, Belinda ;
Greven, Melissa ;
Hardison, Ross C. ;
Harris, Robert S. ;
Herrero, Javier ;
Hoffman, Michael M. ;
Iyer, Sowmya ;
Kellis, Manolis ;
Khatun, Jainab ;
Kheradpour, Pouya ;
Kundaje, Anshul ;
Lassmann, Timo ;
Li, Qunhua ;
Lin, Xinying ;
Marinov, Georgi K. ;
Merkel, Angelika ;
Mortazavi, Ali .
NATURE, 2012, 489 (7414) :57-74
[10]   Epigenome engineering in cancer: fairytale or a realistic path to the clinic? [J].
Falahi, Fahimeh ;
Sgro, Agustin ;
Blancafort, Pilar .
FRONTIERS IN ONCOLOGY, 2015, 5